Reva Medical (ASX:RVA) has won CE Mark clearance for its thin strut Fantom Encore bioresorbable, drug-eluting scaffold.
The sirolimus-eluting vascular scaffold, which is made from Reva’s Tyrocore polymer, features a 95-micron strut profile and x-ray visibility.
Get the full story at our sister site, Drug Delivery Business News.
The post Reva Medical wins CE Mark for bioresorbable Fantom Encore scaffold appeared first on MassDevice.
from MassDevice http://ift.tt/2EUuGQM
Cap comentari:
Publica un comentari a l'entrada